drugset / Trial / NCT01894308
A Dose Ranging Study to Examine TDS-Testosterone 5%
Phase 2
Not yet recruiting
48 enrolled
Transdermal Delivery Solutions Corp
Advanced Therapies Centre, The London Clinic · collab
RandomizedSingle-groupOpen-labelTreatment
Summary
This study is a continuation of previous studies done in healthy volunteers to prove the efficacy of delivering Testosterone, the male hormone, rapidly across intact skin in s series of doses from low to high in men with low-to-no natural testosterone production to measure their response to the varying doses. The results of this study will inform further studies which will be longer in length, as to the starting doses. The study will be conducted in London, U.K. at the Advanced Therapies Centre, The London Clinic.
Timeline
- Start
- 2026-06
- Primary completion
- 2026-10
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Testosterone | Small molecule | 10 mg | Other |
| Comparator | Testosterone | Small molecule | 30 mg | Other |
| Comparator | Testosterone | Small molecule | 50 mg | Other |
| Comparator | Testosterone | Small molecule | 70 mg | Other |